The HHS and other federal agencies must reverse the terminations of probationary government workers that were fired in the states challenging the cuts, under a new order issued Tuesday by a federal ...

Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded ...

Mass firings and forced resignations swept through the FDA on Tuesday, as part of thousands of planned job cuts at federal ...

Compass Therapeutics said Tuesday that adding its bispecific antibody to chemotherapy significantly improved response rates compared to chemotherapy alone in a Phase 2/3 study.

The European Medicines Agency is looking to simplify the way it approves biosimilars by removing the need for “extensive” clinical data, which would likely cut the cost of entry into the market.

Zus Health, led by former athenahealth CEO Jonathan Bush, aims to create unified health records. Company has 60+ customers ...

Axsome Therapeutics said Tuesday that a Phase 3 trial for its narcolepsy drug Sunosi failed to meet its primary goal in major depressive disorder.

GUBamy, AbbVie-licensed amylin drug from Gubra, shows 7.8% weight loss in Phase 1 trial, vs 2% weight gain with placebo after ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

Prazer Therapeutics raises $20M Series B with JJDC's first South Korean investment; Carisma cuts to 6 staff; Cerevance's Parkinson's trial fails; FDA updates for Oncopeptides, Bavarian Nordic ...

Step back from the multitude of details that go into every big pharma pipeline, and you'll see the influence that ...

When the transatlantic startup AIRNA launched in 2023, it was already years behind other companies that were trying to bring ...